News from lonestar heart inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 18, 2014, 11:51 ET

LoneStar Heart informa de una mejora del estado de salud de los pacientes con fallo cardiaco avanzado con Algisyl-LVR®

- LoneStar Heart informa de una mejora considerable en el estado de salud de los pacientes con fallo cardiaco avanzado con los implantes cardiacos...

Nov 18, 2014, 08:30 ET

LoneStar Heart Reports Significant Improvement in Health Status of Advanced Heart Failure Patients Treated with Algisyl-LVR® Cardiac Hydrogel Implants

 LoneStar Heart, Inc. today presented the primary six month results of its multicenter, randomized clinical trial of Algisyl-LVR®...

Nov 18, 2014, 08:30 ET
Nov 18, 2014, 08:30 ET
Oct 01, 2014, 09:46 ET

LoneStar Heart recibe la aprobación europea para comercializar su implante de hidrogel Algisyl-LVR®

- LoneStar Heart recibe la aprobación europea para comercializar su implante de hidrogel Algisyl-LVR® para el tratamiento del fallo...

Oct 01, 2014, 08:53 ET

LoneStar Heart erhält europäische Zulassung für die Vermarktung seines Algisyl-LVR® Hydrogel-Implantats zur Behandlung von fortgeschrittener Herzinsuffizienz

-- Implantierbares Gel könnte die Behandlung von Patienten, welche die Fähigkeit verlieren, Blut effizient durch den Körper zu...

Oct 01, 2014, 08:47 ET

L'Europe accorde à LoneStar Heart l'autorisation de mise sur le marché de son implant hydrogel Algisyl-LVR® destiné au traitement de l'insuffisance cardiaque avancée

-- Un gel implantable pourrait révolutionner le traitement de patients dont le cœur n'assure plus une circulation sanguine efficace....

Oct 01, 2014, 04:00 ET

LoneStar Heart Receives European Approval to Market its Algisyl-LVR® Hydrogel Implant for the Treatment of Advanced Heart Failure

 LoneStar Heart, Inc. today announced that it received the CE Mark (Conformite Europeene) for its Algisyl-LVR® hydrogel implant, the...

May 05, 2014, 08:30 ET

LoneStar Heart achève la phase de recrutement pour son essai clinique randomisé de l'implant hydrogel Algisyl-LVR® dans le traitement de l'insuffisance cardiaque avancée

-- Des résultats sur six mois de l'étude multicentrique AUGMENT-HF devraient être présentés avant la fin de l'année...

May 05, 2014, 08:30 ET

LoneStar Heart komplettiert Rekrutierung für randomisierte klinische Studie zum Algisyl-LVR® Hydrogel-Implantat für fortgeschrittene Herzinsuffizienz

-- Sechsmonatige Ergebnisse der AUGMENT-HF Multicenter-Studie sollen Ende des Jahres präsentiert werden  LoneStar Heart, Inc. hat...

May 05, 2014, 08:30 ET

LoneStar Heart completa el reclutamiento de un ensayo clínico aleatorio del implante de hidrogel Algisyl-LVR®

- LoneStar Heart completa el reclutamiento de un ensayo clínico aleatorio del implante de hidrogel Algisyl-LVR® para fallo cardiaco...

May 05, 2014, 08:30 ET

LoneStar Heart Completes Recruitment for Randomized Clinical Trial of Algisyl-LVR® Hydrogel Implant for Advanced Heart Failure

 LoneStar Heart, Inc. today announced that it completed the patient recruitment phase of the company's AUGMENT-HF controlled randomized...

Nov 20, 2013, 12:29 ET

LoneStar Heart meldet positive Zwischenergebnisse zu Algisyl-LVR® für fortgeschrittene Herzinsuffizienz im Rahmen der aktuellen Klinikstudiensitzung der AHA

-- Ergebnisse einer randomisierten Studie an mehreren Standorten zeigen, dass eine Verstärkung der linken Herzkammer durch ein...

Nov 20, 2013, 08:59 ET

LoneStar Heart presenta los resultados interinos positivos de Algisyl-LVR® para fallo cardiaco avanzado

- LoneStar Heart presenta los resultados interinos positivos de Algisyl-LVR® para fallo cardiaco avanzado en las sesiones de los ensayos...

Nov 20, 2013, 08:30 ET

LoneStar Heart Reports Positive Interim Results of Algisyl-LVR® for Advanced Heart Failure at AHA's Late-Breaking Clinical Trials Sessions

 LoneStar Heart, Inc. today presented the interim results of its multicenter, randomized AUGMENT-HF clinical trial showing left ventricle...

Oct 09, 2012, 08:30 ET

LoneStar Heart Announces $20 Million Milestone Financing for Lead Product to Treat Heart Failure

LoneStar Heart Inc. today announced the completion of an up to $20 million milestone-based equity financing to support the clinical testing and...

Oct 01, 2012, 08:30 ET

LoneStar Heart Announces First Patient in AUGMENT-HF Clinical Trial of Algisyl-LVR™ for the Treatment of Heart Failure

 LoneStar Heart Inc., based here, today announced the first patient was treated in the company's international multi-center AUGMENT-HF clinical...

May 29, 2012, 08:30 ET

Heart Damage Repaired By Reprogramming Resident Fibroblasts into Functioning Heart Cells

 LoneStar Heart Inc., today announced the advancement of a new therapeutic strategy aimed at genetic reprogramming of cardiac fibroblasts...

Jan 24, 2012, 08:30 ET

LoneStar Heart Inc. Names Andrew J. Coats, M.D., and Mark Maciejewski to Its Board of Directors

 LoneStar Heart Inc., based here, today announced that it has elected Andrew J. Coats, M.D., and Mark Maciejewski to the company's board of...